169 related articles for article (PubMed ID: 27618603)
1. Malignant insulinoma: Report of 6 patients and literature review.
Shao Y; Qu YQ; Wang XL; Song ZG; Guo QH; Dou JT; Ba JM; Lü ZH; Mu YM
Neuro Endocrinol Lett; 2016 Jul; 37(3):189-192. PubMed ID: 27618603
[TBL] [Abstract][Full Text] [Related]
2. Management of intractable hypoglycemia with Yttirum-90 radioembolization in a patient with malignant insulinoma.
Chandra P; Yarandi SS; Khazai N; Jacobs S; Umpierrez GE
Am J Med Sci; 2010 Nov; 340(5):414-7. PubMed ID: 20724903
[TBL] [Abstract][Full Text] [Related]
3. Management of a metastasized high grade insulinoma (G3) with refractory hypoglycemia: case report and review of the literature.
Scharf M; Mueller D; Koenig U; Pfestroff A; Nimphius W; Figiel J; Rinke A; Koenig A; Gress T
Pancreatology; 2014; 14(6):542-5. PubMed ID: 25459566
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of metastatic malignant insulinomas. 2 cases].
Mounedji-Boudiaf L; Rougier P; Culine S; de Baere T; Lasser P; Escudier B; Ducreux M; Kaloustian E; Droz JP; Roche A
Presse Med; 1995 May; 24(19):894-6. PubMed ID: 7638129
[TBL] [Abstract][Full Text] [Related]
5. Malignant metastatic insulinoma-postoperative treatment and follow-up.
Starke A; Saddig C; Mansfeld L; Koester R; Tschahargane C; Czygan P; Goretzki P
World J Surg; 2005 Jun; 29(6):789-93. PubMed ID: 15880279
[TBL] [Abstract][Full Text] [Related]
6. Metastatic insulinoma: case report and review of the literature.
Tran TH; Pathak RD; Basa AL
South Med J; 2004 Feb; 97(2):199-201. PubMed ID: 14982275
[TBL] [Abstract][Full Text] [Related]
7. Insulinoma: A retrospective study analyzing the differences between benign and malignant tumors.
Câmara-de-Souza AB; Toyoshima MTK; Giannella ML; Freire DS; Camacho CP; Lourenço DM; Rocha MS; Bacchella T; Jureidini R; Machado MCC; Almeida MQ; Pereira MAA
Pancreatology; 2018 Apr; 18(3):298-303. PubMed ID: 29452754
[TBL] [Abstract][Full Text] [Related]
8. Pasireotide for Refractory Hypoglycemia in Malignant Insulinoma- Case Report and Review of the Literature.
Oziel-Taieb S; Maniry-Quellier J; Chanez B; Poizat F; Ewald J; Niccoli P
Front Endocrinol (Lausanne); 2022; 13():860614. PubMed ID: 35518928
[TBL] [Abstract][Full Text] [Related]
9. [Malignant insulinoma: recommendations for workup and treatment].
Baudin E; Caron P; Lombard-Bohas C; Tabarin A; Mitry E; Reznick Y; Taieb D; Pattou F; Goudet P; Vezzosi D; Scoazec JY; Cadiot G; Borson-Chazot F; Do Cao C;
Presse Med; 2014 Jun; 43(6 Pt 1):645-59. PubMed ID: 24857257
[TBL] [Abstract][Full Text] [Related]
10. Changing Insulinoma Management Due to Incidentally Discovered Metastasis: A Case Report.
Madan R; Mettler T; Froelich J; Chow LS
Am J Case Rep; 2020 Jun; 21():e923356. PubMed ID: 32535614
[TBL] [Abstract][Full Text] [Related]
11. Complete clinical remission and disappearance of liver metastases after treatment with somatostatin analogue in a 40-year-old woman with a malignant insulinoma positive for somatostatin receptors type 2.
Romeo S; Milione M; Gatti A; Fallarino M; Corleto V; Morano S; Baroni MG
Horm Res; 2006; 65(3):120-5. PubMed ID: 16479142
[TBL] [Abstract][Full Text] [Related]
12. Strategy for the surgical management of insulinomas: analysis of 52 cases.
Liu H; Peng C; Zhang S; Wu Y; Fang H; Sheng H; Peng S
Dig Surg; 2007; 24(6):463-70. PubMed ID: 18057893
[TBL] [Abstract][Full Text] [Related]
13. Management of malignant insulinoma.
Ferrer-García JC; Iranzo González-Cruz V; Navas-DeSolís S; Civera-Andrés M; Morillas-Ariño C; Merchante-Alfaro A; Caballero-Díaz C; Sánchez-Juan C; Camps Herrero C
Clin Transl Oncol; 2013 Sep; 15(9):725-31. PubMed ID: 23460559
[TBL] [Abstract][Full Text] [Related]
14. Surgical management of insulinomas: short- and long-term outcomes after enucleations and pancreatic resections.
Crippa S; Zerbi A; Boninsegna L; Capitanio V; Partelli S; Balzano G; Pederzoli P; Di Carlo V; Falconi M
Arch Surg; 2012 Mar; 147(3):261-6. PubMed ID: 22430908
[TBL] [Abstract][Full Text] [Related]
15. Diazoxide in the management of patients with insulinoma.
Goode PN; Farndon JR; Anderson J; Johnston ID; Morte JA
World J Surg; 1986 Aug; 10(4):586-92. PubMed ID: 3019020
[No Abstract] [Full Text] [Related]
16. Radio-frequency ablation for symptom control in a patient with metastatic pancreatic insulinoma.
Scott A; Hinwood D; Donnelly R
Clin Endocrinol (Oxf); 2002 Apr; 56(4):557-9. PubMed ID: 11966750
[TBL] [Abstract][Full Text] [Related]
17. Improved control of severe hypoglycemia in patients with malignant insulinomas by peptide receptor radionuclide therapy.
van Schaik E; van Vliet EI; Feelders RA; Krenning EP; Khan S; Kamp K; Valkema R; van Nederveen FH; Teunissen JJ; Kwekkeboom DJ; de Herder WW
J Clin Endocrinol Metab; 2011 Nov; 96(11):3381-9. PubMed ID: 21917872
[TBL] [Abstract][Full Text] [Related]
18. Transformation of nonfunctioning pancreatic tumor into malignant insulinoma after 3 years: an uncommon clinical course of insulinoma.
Arslan MS; Ozbek M; Karakose M; Tutal E; Ucan B; Yilmazer D; Dilli A; Gultekin SS; Cakal E; Delibasi T
Arch Endocrinol Metab; 2015 Jun; 59(3):270-2. PubMed ID: 26154097
[TBL] [Abstract][Full Text] [Related]
19. Malignant insulinoma misdiagnosed and treated as epilepsy.
Louda F; Chadli A; Elaziz S; Elghomari H; Farouqi A
Ann Endocrinol (Paris); 2013 Feb; 74(1):53-5. PubMed ID: 23351560
[TBL] [Abstract][Full Text] [Related]
20. Giant insulinoma: a report of 3 cases and review of the literature.
Callacondo D; Arenas JL; Ganoza AJ; Rojas-Camayo J; Quesada-Olarte J; Robledo H
Pancreas; 2013 Nov; 42(8):1323-32. PubMed ID: 24152958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
